Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-2404, USA.
Planta Med. 2010 Mar;76(5):500-1. doi: 10.1055/s-0029-1240617. Epub 2009 Nov 25.
The purpose of this study was to attempt the reproducible coculture of more than two fungi for biosynthesis of potential antineoplastic substances. Five different fungi were simultaneously inoculated into broth cultures and grown for two weeks. Cancer cell line bioassay-guided fractionation, NMR, and mass spectroscopy led to the isolation and characterization of lateritin. Lateritin inhibited the growth of a mini-panel of human cancer cell lines, gram-positive bacteria, and Candida albicans. Individually, the five fungi did not synthesize detectable levels of lateritin. This study adds to the small but growing body of evidence that mixed fermentation is a viable avenue for natural product drug discovery. In addition, this is the first report of the reproducible coculture of more than two microbes for natural product biosynthesis, and the first report of the human solid tumor cell line and antimicrobial activities of lateritin.
本研究旨在尝试重复培养两种以上真菌以合成潜在的抗肿瘤物质。将五种不同的真菌同时接种到肉汤培养基中并培养两周。采用癌细胞系生物测定指导的分步提取、NMR 和质谱分析,分离并鉴定出了 lateritin。Lateritin 抑制了一个小型人类癌细胞系、革兰氏阳性菌和白色念珠菌的生长。单独来看,这五种真菌均未合成可检测水平的 lateritin。这项研究增加了越来越多的证据,即混合发酵是天然产物药物发现的可行途径。此外,这是首次报道重复培养两种以上微生物进行天然产物生物合成,也是首次报道 lateritin 的人类实体瘤细胞系和抗微生物活性。